Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Corcept Therapeutics Inc (CORT)  
$25.32 0.57 (2.3%) as of 4:30 Wed 3/27


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 116,630,000
Market Cap: 2.95(B)
Last Volume: 746,706 Avg Vol: 990,062
52 Week Range: $21.1 - $33.8
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Corcept Therapeutics is a commercial-stage company engaged in the discovery and development of drugs that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effects of the hormone cortisol. Co. has marketed Korlym (mifepristone) in the U.S. for the treatment of patients with Cushing's syndrome. Co.'s primary compounds have entered the clinic as potential treatments for serious disorders, including Cushing's syndrome, solid tumors (such as ovarian cancer, castration-resistant prostate cancer and adrenocortical cancer with cortisol excess), antipsychotic induced weight gain and non-alcoholic steatohepatitis.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 56,647 138,640 284,695 894,325
Total Sell Value $1,427,320 $3,654,693 $7,853,505 $23,622,534
Total People Sold 3 5 7 8
Total Sell Transactions 7 20 33 51
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 485
  Page 1 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Maduck Sean See Remarks   •       –      –    2024-03-19 4 OE $2.61 $26,100 D/D 10,000 85,222     -
   Maduck Sean See Remarks   •       –      –    2024-03-18 4 AS $25.00 $430,475 D/D (17,219) 75,222 1%     
   Maduck Sean See Remarks   •       –      –    2024-03-18 4 OE $3.88 $66,810 D/D 17,219 92,441     -
   Maduck Sean See Remarks   •       –      –    2024-03-01 4 A $0.00 $15,302 D/D 1,272 75,222     -
   Maduck Sean See Remarks   •       –      –    2024-03-01 4 D $24.06 $12,150 D/D (505) 73,950     -
   Robb Gary Charles Chief Business Officer   •       –      –    2024-03-01 4 A $0.00 $16,770 D/D 1,394 20,203     -
   Robb Gary Charles Chief Business Officer   •       –      –    2024-03-01 4 D $24.06 $15,783 D/D (656) 18,809     -
   Guyer William Chief Development Officer   •       –      –    2024-03-01 4 D $24.06 $14,532 D/D (604) 6,039     -
   Lyon Joseph Douglas Chief Accounting Officer   •       –      –    2024-03-01 4 A $0.00 $12,198 D/D 1,014 7,314     -
   Lyon Joseph Douglas Chief Accounting Officer   •       –      –    2024-03-01 4 D $24.06 $11,404 D/D (474) 6,300     -
   Swisher Daniel N Jr   –       •      –    2024-03-01 4 AS $23.59 $51,898 D/D (2,200) 0 2%     
   Swisher Daniel N Jr   –       •      –    2024-03-01 4 OE $5.86 $12,892 D/D 2,200 2,200     -
   Mokari Atabak Chief Financial Officer   •       –      –    2024-03-01 4 A $0.00 $13,329 D/D 1,108 9,536     -
   Mokari Atabak Chief Financial Officer   •       –      –    2024-03-01 4 D $24.06 $12,439 D/D (517) 8,428     -
   Lyon Joseph Douglas Chief Accounting Officer   •       –      –    2024-02-16 4 AS $26.00 $26,000 D/D (1,000) 6,774 8%     
   Lyon Joseph Douglas Chief Accounting Officer   •       –      –    2024-02-16 4 OE $11.35 $11,350 D/D 1,000 7,774     -
   Maduck Sean See Remarks   •       –      –    2024-02-16 4 AS $25.97 $702,905 D/D (27,068) 74,455 8%     
   Maduck Sean See Remarks   •       –      –    2024-02-16 4 OE $3.29 $97,811 D/D 27,068 101,523     -
   Maduck Sean See Remarks   •       –      –    2024-02-15 4 AS $25.00 $119,000 D/D (4,760) 74,455 0%     
   Maduck Sean See Remarks   •       –      –    2024-02-15 4 OE $3.29 $15,660 D/D 4,760 79,215     -
   Swisher Daniel N Jr   –       •      –    2024-02-01 4 AS $22.00 $48,400 D/D (2,200) 0 13%     
   Swisher Daniel N Jr   –       •      –    2024-02-01 4 OE $5.86 $12,892 D/D 2,200 2,200     -
   Hunt Hazel Chief Scientific Officer   •       –      –    2024-01-08 4 D $27.46 $818,088 D/D (29,792) 93,354     -
   Hunt Hazel Chief Scientific Officer   •       –      –    2024-01-08 4 OE $3.02 $151,000 D/D 50,000 123,146     -
   Swisher Daniel N Jr   –       •      –    2024-01-02 4 AS $22.11 $48,642 D/D (2,200) 0 1%     

  485 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed